0001654954-22-012673.txt : 20220919 0001654954-22-012673.hdr.sgml : 20220919 20220919161625 ACCESSION NUMBER: 0001654954-22-012673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220914 FILED AS OF DATE: 20220919 DATE AS OF CHANGE: 20220919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maggiore Christopher D. CENTRAL INDEX KEY: 0001436075 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40449 FILM NUMBER: 221250792 MAIL ADDRESS: STREET 1: 4788 NOBLES POND DR. NW CITY: CANTON STATE: OH ZIP: 44718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 4 1 section16.xml FORM 4 X0306 4 2022-09-14 0001101026 Zivo Bioscience, Inc. ZIVO 0001436075 Maggiore Christopher D. 4788 NOBLES POND DR. NW CANTON OH 44718 true true Common Stock 2022-09-14 4 P false 5200 3.5281 A 808305 D Common Stock 2022-09-14 4 P false 2000 3.5507 A 810305 D The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.45 to $3.7257 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.435 to $3.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Christopher D. Maggiore 2022-09-19